Condition
Chronic Bronchitis
ClinicalTrials.gov condition label
Clinical trials
60 shownClinical Study of the Pulsed Electric Field Ablation System in Chronic Obstructive Pulmonary DiseaseNCT07068438 · 2025-09-01
RECRUITINGCOPD Patient-Powered Research NetworkNCT02803242 · 2014-08-01
RECRUITINGEmphysema Research Registry and Biosample RepositoryNCT00307281 · 2000-08-01
RECRUITINGRepeat Treatment With Metered Cryospray in Patients With Chronic Obstructive Pulmonary Disease With Chronic BronchitisNCT07468617 · 2027-01-02
NOT_YET_RECRUITINGPulmonary Deposition of Ultrasound Rock Salt Aerosol Inhalation TherapyNCT06891274 · 2025-03-31
NOT_YET_RECRUITINGA Clinical Evaluation of the RheOx Bronchial Rheoplasty SystemNCT05641207 · 2023-05-18
COMPLETEDFeasibility Study of the Pulsed Electric Field Ablation System in Treating Chronic BronchitisNCT05771129 · 2023-03-10
UNKNOWNStructuring of a Lung Cancer Screening Program Including Clinical, Radiological and Biological Phenotyping Useful for the Development of Individualized Risk Prediction Tools: PREVALUNG ETOILENCT05649046 · 2023-01-23
UNKNOWNPulmonary and Cardiac Effects of E-Cigarette Use in Pulmonary Patients Who Smoke CigarettesNCT05610514 · 2022-04-28
COMPLETEDEvaluation of Immunological, Microbiological and Metabolomic Profiles in COPDNCT06826560 · 2022-03-01
COMPLETEDA Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in ChinaNCT05337163 · 2022-02-25
COMPLETEDImmunogenicity and Safety of a Third Dose and Immune Persistence of BBIBP-Corv Vaccine in Elderly People With Chronic Bronchitis and COPDNCT05104216 · 2021-12-01
UNKNOWNImmunogenicity and Safety of an Inactivated COVID-19 Vaccine in Elderly People With Chronic Bronchitis and COPDNCT05075083 · 2021-10-08
UNKNOWNImmunogenicity and Safety of an Inactivated COVID-19 Vaccine in Patients Aged ≥60 Years With Chronic Bronchitis and COPDNCT05075057 · 2021-10-08
UNKNOWNEffect of Zhuli Capsule on Phlegm-heat Syndrome (Tan-re Zheng)NCT04834531 · 2021-07-01
UNKNOWNClinical Study of the RheOx Bronchial Rheoplasty System in Treating the Symptoms of Chronic BronchitisNCT04677465 · 2021-04-07
UNKNOWNA Study to Assess the Safety, Tolerability, and Efficacy of ION-827359 in Participants With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis (CB)NCT04441788 · 2020-12-22
TERMINATEDA Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess MEDI3506 in Participants With COPD and Chronic BronchitisNCT04631016 · 2020-12-14
COMPLETEDRejuvenAir® System Trial for COPD With Chronic BronchitisNCT03893370 · 2020-07-09
UNKNOWNMetered Cryospray for the Treatment of Patients With Chronic Obstructive Pulmonary Disease With Chronic BronchitisNCT03892694 · 2020-02-14
COMPLETEDRoflumilast or Azithromycin to Prevent COPD Exacerbations TrialNCT04069312 · 2020-02-11
COMPLETEDRheOx Registry Study in EuropeNCT04182841 · 2020-01-09
UNKNOWNMortality and Symptom Burden Post Hospitalisation With COPDNCT03657121 · 2019-01-16
COMPLETEDGala Early Feasibility Study of RheOxNCT03631472 · 2018-07-06
UNKNOWNMelodica Orchestra for Dyspnea: Safety and Feasibility PilotNCT03653104 · 2018-06-12
WITHDRAWNGala Treatment for Chronic Bronchitis in CanadaNCT03385616 · 2017-08-24
COMPLETEDCrossover Blinded Trial of Cell Therapy Versus Placebo in COPDNCT03228121 · 2017-04-24
WITHDRAWNThe Topic Trial - Study to Determine the Safety and Efficacy of IvacaftorNCT03085485 · 2017-03-16
COMPLETEDStudying the Airway Microenvironment in Patients Undergoing Surgical and Bronchoscopic Interventions for COPDNCT03010592 · 2017-02-06
UNKNOWNBROnchoalveolar Investigations of Never-smokers With Chronic Obstruction From the Swedish CardioPulmonary bioImage StudyNCT03049202 · 2017-02-01
ACTIVE_NOT_RECRUITINGThe Relationship Between GOLD Risk Group and Clinical Outcomes in a Community-based COPD CohortNCT02838108 · 2016-10-01
TERMINATEDActivity Monitor Use in COPD Patients Undergoing RehabilitationNCT02895152 · 2016-08-01
COMPLETEDNovel Therapies for Muco-Obstructive Lung Diseases: Testing the Transnasal Pulmonary Delivery Device in COPD/CB SubjectsNCT02341183 · 2016-05-01
WITHDRAWNPatient-Centred Innovations for Persons With Multimorbidity - QuebecNCT02789800 · 2016-04-22
COMPLETEDEffect of Losartan on Airway Mucociliary Dysfunction in Patients With COPD and Chronic BronchitisNCT02416102 · 2016-03-31
TERMINATEDPatient-Centred Innovations for Persons With Multimorbidity - OntarioNCT02742597 · 2016-01-12
COMPLETEDThe Effect of Physical Activity Promotion on Short and Long-term Outcomes in COPDNCT02099799 · 2015-11-17
COMPLETEDA Comparison Study of Two Respiratory Physical Therapy Methods and Standard Medical Treatment for Treating COPD Patients During Acute ExacerbationNCT02140892 · 2014-07-01
UNKNOWNEvaluation of the Safety of the Medical Device Simeox®NCT02061852 · 2014-07-01
TERMINATEDMindfulness-based Cognitive Therapy for Chronic Obstructive Pulmonary DiseaseNCT02042976 · 2014-02-01
COMPLETEDPostoperative Rehabilitation After Cardiac Surgery in Patients at Risk of Respiratory Complications. Effects of a Continuous Bi-laterosternal Infusion of Ropivacaine Through Multihole CathetersNCT01828788 · 2013-04-27
COMPLETEDThe Effectiveness of Roflumilast in Improving Mucociliary Clearance in Patients With COPD and Chronic BronchitisNCT03073798 · 2013-03-18
COMPLETEDSustained Effects of Hypertonic Saline on Mucociliary Clearance in Subjects With Chronic BronchitisNCT01792271 · 2013-02-01
COMPLETEDN-Acetylcysteine for Patients With COPD and Chronic BronchitisNCT01739790 · 2013-01-01
TERMINATEDN-Acetylcysteine for Patients With COPD and ChronicBronchitisNCT01599884 · 2012-06-01
UNKNOWNSunovion Brovana Versus Serevent Inspiratory Capacity High Resolution Computed TomographyNCT01361984 · 2011-06-01
UNKNOWNA Study to Evaluate the Integrated Dose Counter on an Albuterol Hydrofluoroalkane (HFA) Metered Dose Inhaler (MDI)NCT01302587 · 2011-03-01
COMPLETEDEffects of Exercise Training on Systemic Inflammation an Muscle Repair According to the Obstructive Chronic Pulmonary Disease (COPD) PhenotypeNCT01431625 · 2011-01-01
UNKNOWNStudy of COPD Subgroups and BiomarkersNCT01969344 · 2010-11-01
ACTIVE_NOT_RECRUITINGEpidemiology of Chronic Bronchitis in Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT02128529 · 2010-10-01
COMPLETEDThe Effect of Azithromycin in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Chronic Productive CoughNCT01071161 · 2009-09-01
COMPLETEDThe Natural History of Gene Expression in the Lung Cells of Non-Smokers, Smokers and Ex-Smokers in Health and DiseaseNCT00974064 · 2009-08-01
COMPLETEDCryoSpray Ablation(tm)Thoracic Patient RegistryNCT00785239 · 2009-04-01
WITHDRAWNEfficacy of Losartan in Preventing Progression of COPDNCT00720226 · 2008-07-01
COMPLETEDPROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)NCT00683722 · 2008-03-20
COMPLETEDPerforomist Versus Foradil Evaluated by Inspiratory Capacity and High Resolution Computed Tomography (HRCT)NCT00633776 · 2008-03-01
WITHDRAWNMoxifloxacin Versus Amoxicillin Clavulanic Acid in Treatment of Acute Exacerbation of Chronic BronchitisNCT00656747 · 2008-03-01
COMPLETEDThe Effects of Tiotropium on the Cough Reflex in Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT00870896 · 2008-02-01
COMPLETEDAdd-on Effects of Tiotropium Over Formoterol in Exercise Tolerance on Chronic Obstructive Pulmonary Disease PatientsNCT00680056 · 2007-11-01
COMPLETEDPulmonary Function Changes in 10 Pack Year Smokers With Chronic BronchitisNCT00454675 · 2007-03-01
COMPLETEDCommon interventions
placeboDRUG10Inactivated COVID-19 vaccineBIOLOGICAL3SalmeterolDRUG3AzithromycinDRUG2N-acetylcysteineDRUG2RejuvenAir SystemDEVICE2RheOxDEVICE2RoflumilastDRUG2Sham ProcedureDEVICE27% hypertonic salineOTHER17% hypertonic saline (510K approved as a device)DEVICE1AlbuterolDRUG1Amoxicillin clavulanic acidDRUG1arformoterolDRUG1arformoterol tartrate inhalation solutionDRUG1Audit and FeedbackBEHAVIORAL1Avelox (Moxifloxacin, BAY12-8039)DRUG1azithromycin and fluticasoneDRUG1BLOOD SAMPLEBIOLOGICAL1chest CT or pathological examinationPROCEDURE1Coached exercise persistence interventionBEHAVIORAL1Combined Training (endurance and strength exercises)OTHER1Diagnostic Test: Sputum DNA methylation analysisDIAGNOSTIC_TEST1DIMAC02BEHAVIORAL1E-CigaretteOTHER1
Leading sponsors
Imperial College London5CSA Medical, Inc.4Gala Therapeutics, Inc.4Johns Hopkins University4University of North Carolina, Chapel Hill4China National Biotec Group Company Limited3AstraZeneca2Karolinska Institutet2Sumitomo Pharma America, Inc.2University of California, Los Angeles2VA Office of Research and Development2Adams Respiratory Therapeutics1Assistance Publique Hopitaux De Marseille1Bayer1Center for Veterans Research and Education1
Trial status mix
COMPLETED43
UNKNOWN15
TERMINATED7
WITHDRAWN6
ACTIVE_NOT_RECRUITING3
RECRUITING3
NOT_YET_RECRUITING2
Phase mix
NA28
PHASE414
PHASE210
PHASE34
PHASE12
EARLY_PHASE11
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.